{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:46:14Z","timestamp":1792403174633,"version":"4.4.0"},"publisher-location":"Berlin, Heidelberg","reference-count":149,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662558782","type":"print"},{"value":"9783662558805","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/7854_2017_478","type":"book-chapter","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T07:40:37Z","timestamp":1499154037000},"page":"45-73","source":"Crossref","is-referenced-by-count":258,"title":["Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways"],"prefix":"10.1007","author":[{"given":"Juan F.","family":"L\u00f3pez-Gim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"478_CR1","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","volume":"29","author":"AI Abbas","year":"2009","unstructured":"Abbas AI, Yadav PN, Yao W-D, Arbuckle MI, Grant SGN, Caron MG, Roth BL (2009) PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J Neurosci 29:7124\u20137136","journal-title":"J Neurosci"},{"key":"478_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0091-3057(85)90022-X","volume":"23","author":"LM Adams","year":"1985","unstructured":"Adams LM, Geyer MA (1985) Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide. Pharmacol Biochem Behav 23:461\u2013468","journal-title":"Pharmacol Biochem Behav"},{"key":"478_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00213-009-1484-9","volume":"206","author":"GK Aghajanian","year":"2009","unstructured":"Aghajanian GK (2009) Modeling, \u201cpsychosis\u201d in vitro by inducing disordered neuronal network activity in cortical brain slices. Psychopharmacology 206:575\u2013585","journal-title":"Psychopharmacology"},{"key":"478_CR4","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1016\/S0893-133X(98)00135-3","volume":"21","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21:16S\u201323S","journal-title":"Neuropsychopharmacology"},{"key":"478_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","volume":"31","author":"GK Aghajanian","year":"2000","unstructured":"Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31:302\u2013312","journal-title":"Brain Res Brain Res Rev"},{"key":"478_CR6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.161.3842.706","volume":"161","author":"GK Aghajanian","year":"1968","unstructured":"Aghajanian GK, Foote WE, Sheard MH (1968) Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science 161:706\u2013708","journal-title":"Science"},{"key":"478_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-3565(25)23167-6","volume":"255","author":"NM Appel","year":"1990","unstructured":"Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB (1990) Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. J Pharmacol Exp Ther 255:843\u2013857","journal-title":"J Pharmacol Exp Ther"},{"key":"478_CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cell.2012.09.003","volume":"151","author":"M Audet","year":"2012","unstructured":"Audet M, Bouvier M (2012) Restructuring G-protein-coupled receptor activation. Cell 151:14\u201323","journal-title":"Cell"},{"key":"478_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00424-015-1780-7","volume":"468","author":"L Baki","year":"2016","unstructured":"Baki L, Fribourg M, Younkin J, Eltit JM, Moreno JL, Park G, Vysotskaya Z, Narahari A, Sealfon SC, Gonzalez-Maeso J, Logothetis DE (2016) Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells. Pflugers Arch 468:775\u2013793","journal-title":"Pflugers Arch"},{"key":"478_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BJ20101844","volume":"436","author":"Z Barclay","year":"2011","unstructured":"Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R (2011) 5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail. Biochem J 436:651\u2013660","journal-title":"Biochem J"},{"key":"478_CR11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"478_CR12","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1074\/jbc.M008089200","volume":"276","author":"C Becamel","year":"2001","unstructured":"Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lubbert H, Ullmer C (2001) Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 276:12974\u201312982","journal-title":"J Biol Chem"},{"key":"478_CR13","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/emboj\/21.10.2332","volume":"21","author":"C Becamel","year":"2002","unstructured":"Becamel C, Alonso G, Galeotti N, Demey E, Jouin P, Ullmer C, Dumuis A, Bockaert J, Marin P (2002a) Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach. EMBO J 21:2332\u20132342","journal-title":"EMBO J"},{"key":"478_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1251\/bpo39","volume":"4","author":"C Becamel","year":"2002","unstructured":"Becamel C, Galeotti N, Poncet J, Jouin P, Dumuis A, Bockaert J, Marin P (2002b) A proteomic approach based on peptide affinity chromatography, 2-dimensional electrophoresis and mass spectrometry to identify multiprotein complexes interacting with membrane-bound receptors. Biol Proced Online 4:94\u2013104","journal-title":"Biol Proced Online"},{"key":"478_CR15","doi-asserted-by":"crossref","first-page":"20257","DOI":"10.1074\/jbc.M312106200","volume":"279","author":"C Becamel","year":"2004","unstructured":"Becamel C, Gavarini S, Chanrion B, Alonso G, Galeotti N, Dumuis A, Bockaert J, Marin P (2004) The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J Biol Chem 279:20257\u201320266","journal-title":"J Biol Chem"},{"key":"478_CR16","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.0700436104","volume":"104","author":"JC Beique","year":"2007","unstructured":"Beique JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (2007) Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci U S A 104:9870\u20139875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","volume":"54","author":"KA Berg","year":"1998","unstructured":"Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94\u2013104","journal-title":"Mol Pharmacol"},{"key":"478_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355\u2013366","journal-title":"Annu Rev Med"},{"key":"478_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1471-4159.2009.06493.x","volume":"112","author":"A Bhattacharya","year":"2010","unstructured":"Bhattacharya A, Sankar S, Panicker MM (2010) Differences in the C-terminus contribute to variations in trafficking between rat and human 5-HT(2A) receptor isoforms: identification of a primate-specific tripeptide ASK motif that confers GRK-2 and beta arrestin-2 interactions. J Neurochem 112:723\u2013732","journal-title":"J Neurochem"},{"key":"478_CR20","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.212517999","volume":"99","author":"S Bhattacharyya","year":"2002","unstructured":"Bhattacharyya S, Puri S, Miledi R, Panicker MM (2002) Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci U S A 99:14470\u201314475","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR21","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1113\/jphysiol.2014.272252","volume":"592","author":"M Bouvier","year":"2014","unstructured":"Bouvier M, Hebert TE (2014) CrossTalk proposal: weighing the evidence for Class A GPCR dimers, the evidence favours dimers. J Physiol 592:2439\u20132441","journal-title":"J Physiol"},{"key":"478_CR22","doi-asserted-by":"crossref","unstructured":"Canal CE (2012) Head\u2010twitch response in rodents induced by the hallucinogen 2, 5\u2010dimethoxy\u20104\u2010iodoamphetamine: a comprehensive history, a re\u2010evaluation of mechanisms, and its \u2026. Drug Testing and Analysis","DOI":"10.1002\/dta.1333"},{"key":"478_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-010-1784-0","volume":"209","author":"CE Canal","year":"2010","unstructured":"Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC (2010) The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology 209:163\u2013174","journal-title":"Psychopharmacology"},{"issue":"5","key":"478_CR24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2008.03.013","volume":"64","author":"Pau Celada","year":"2008","unstructured":"Celada P, Puig MV, Diaz-Mataix L, Artigas F (2008) The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biol Psychiatry 64:392\u2013400","journal-title":"Biological Psychiatry"},{"key":"478_CR25","doi-asserted-by":"crossref","unstructured":"Chiu HY, Chan MH, Lee MY, Chen ST, Zhan ZY, Chen HH (2014) Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice. Int J Neuropsychopharmacol 1\u201312","DOI":"10.1017\/S1461145714000455"},{"key":"478_CR26","unstructured":"Clark AJ (1933) The mode of action of drugs on cells"},{"key":"478_CR27","unstructured":"Dahlstr\u00f6m A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl SUPPL 232:231\u2013255"},{"key":"478_CR28","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1016\/S0021-9258(20)79672-9","volume":"255","author":"A Lean De","year":"1980","unstructured":"De Lean A, Stadel JM, Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255:7108\u20137117","journal-title":"J Biol Chem"},{"key":"478_CR29","unstructured":"Delille HK, Becker JM, Burkhardt S, Bleher B, Terstappen GC, Schmidt M, Meyer AH, Unger L, Marek GJ, Mezler M (2012) Heterocomplex formation of 5-HT(2A)-mGlu(2) and its relevance for cellular signaling cascades. Neuropharmacology 1\u20138"},{"key":"478_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s002130050585","volume":"136","author":"CT Egan","year":"1998","unstructured":"Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M (1998) Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors. Psychopharmacology 136:409\u2013414","journal-title":"Psychopharmacology"},{"key":"478_CR31","first-page":"445","volume":"2","author":"P Erhlich","year":"1913","unstructured":"Erhlich P (1913) Chemotherapeutics: scientific principles, methods and results. Lancet 2:445\u2013451","journal-title":"Lancet"},{"key":"478_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","volume":"75","author":"WE Fantegrossi","year":"2008","unstructured":"Fantegrossi WE, Murnane KS, Reissig CJ (2008) The behavioral pharmacology of hallucinogens. Biochem Pharmacol 75:17\u201333","journal-title":"Biochem Pharmacol"},{"key":"478_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","volume":"53","author":"SS Ferguson","year":"2001","unstructured":"Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1\u201324","journal-title":"Pharmacol Rev"},{"key":"478_CR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","volume":"66","author":"S Ferre","year":"2014","unstructured":"Ferre S, Casado V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev 66:413\u2013434","journal-title":"Pharmacol Rev"},{"key":"478_CR35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3565(24)37202-7","volume":"284","author":"JA Florian","year":"1998","unstructured":"Florian JA, Watts SW (1998) Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J Pharmacol Exp Ther 284:346\u2013355","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"478_CR36","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/mp.2014.166","volume":"20","author":"A L Frederick","year":"2015","unstructured":"Frederick A. L., Yano H., Trifilieff P, Vishwasrao HD, Biezonski D, Meszaros J, Urizar E, Sibley DR, Kellendonk C, Sonntag KC, Graham DL, Colbran RJ, Stanwood GD, Javitch JA (2015) Evidence against dopamine D1\/D2 receptor heteromers. Mol Psychiatry","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"478_CR37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","volume":"147","author":"Miguel Fribourg","year":"2011","unstructured":"Fribourg M, Moreno JL, Holloway T, Provasi D, Baki L, Mahajan R, Park G, Adney SK, Hatcher C, Eltit JM, Ruta JD, Albizu L, Li Z, Umali A, Shim J, Fabiato A, Mackerell AD Jr, Brezina V, Sealfon SC, Filizola M, Gonzalez-Maeso J, Logothetis DE (2011) Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell 147:1011\u20131023","journal-title":"Cell"},{"key":"478_CR38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1476-5381.1957.tb00142.x","volume":"12","author":"JH Gaddum","year":"1957","unstructured":"Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol Chemother 12:323\u2013328","journal-title":"Br J Pharmacol Chemother"},{"key":"478_CR39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.neuropharm.2007.03.013","volume":"52","author":"EE Garcia","year":"2007","unstructured":"Garcia EE, Smith RL, Sanders-Bush E (2007) Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology 52:1671\u20131677","journal-title":"Neuropharmacology"},{"key":"478_CR40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"CR Gerfen","year":"1992","unstructured":"Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133\u2013139","journal-title":"Trends Neurosci"},{"key":"478_CR41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0893-133X(00)00136-6","volume":"23","author":"JC Gewirtz","year":"2000","unstructured":"Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23:569\u2013576","journal-title":"Neuropsychopharmacology"},{"key":"478_CR42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0091-3057(02)00844-4","volume":"73","author":"JC Gewirtz","year":"2002","unstructured":"Gewirtz JC, Chen AC, Terwilliger R, Duman RC, Marek GJ (2002) Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors. Pharmacol Biochem Behav 73:317\u2013326","journal-title":"Pharmacol Biochem Behav"},{"key":"478_CR43","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505\u20132511","journal-title":"Life Sci"},{"key":"478_CR44","first-page":"953","volume":"22","author":"RA Glennon","year":"1986","unstructured":"Glennon RA, Titeler M, Young R (1986) Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. Psychopharmacol Bull 22:953\u2013958","journal-title":"Psychopharmacol Bull"},{"key":"478_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1756-6606-4-20","volume":"4","author":"J Gonzalez-Maeso","year":"2011","unstructured":"Gonzalez-Maeso J (2011) GPCR oligomers in pharmacology and signaling. Mol Brain 4:20","journal-title":"Mol Brain"},{"key":"478_CR46","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","volume":"23","author":"J Gonzalez-Maeso","year":"2003","unstructured":"Gonzalez-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M, Weisstaub N, Hen R, Gingrich JA, Sealfon SC (2003) Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci 23:8836\u20138843","journal-title":"J Neurosci"},{"key":"478_CR47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) Receptor-mediated signaling pathways to affect behavior. Neuron 53:439\u2013452","journal-title":"Neuron"},{"key":"478_CR48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","volume":"452","author":"J Gonzalez-Maeso","year":"2008","unstructured":"Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC (2008) Identification of a serotonin\/glutamate receptor complex implicated in psychosis. Nature 452:93\u201397","journal-title":"Nature"},{"key":"478_CR49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0166-2236(90)90104-I","volume":"13","author":"AM Graybiel","year":"1990","unstructured":"Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244\u2013254","journal-title":"Trends Neurosci"},{"key":"478_CR50","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjp.2008.207","volume":"154","author":"AR Green","year":"2008","unstructured":"Green AR (2008) Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK. Br J Pharmacol 154:1583\u20131599","journal-title":"Br J Pharmacol"},{"key":"478_CR51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrd3702","volume":"11","author":"G Griebel","year":"2012","unstructured":"Griebel G, Holsboer F (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov 11:462\u2013478","journal-title":"Nat Rev Drug Discov"},{"key":"478_CR52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","volume":"277C","author":"AL Halberstadt","year":"2015","unstructured":"Halberstadt AL (2015) Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 277C:99\u2013120","journal-title":"Behav Brain Res"},{"key":"478_CR53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cn300138m","volume":"4","author":"JB Hanks","year":"2013","unstructured":"Hanks JB, Gonzalez-Maeso J (2013) Animal models of serotonergic psychedelics. ACS Chem Neurosci 4:33\u201342","journal-title":"ACS Chem Neurosci"},{"key":"478_CR54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","volume":"195","author":"J Hannon","year":"2008","unstructured":"Hannon J, Hoyer D (2008) Molecular biology of 5-HT receptors. Behav Brain Res 195:198\u2013213","journal-title":"Behav Brain Res"},{"key":"478_CR55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.pharmtox.48.113006.094830","volume":"48","author":"AC Hanyaloglu","year":"2008","unstructured":"Hanyaloglu AC, von Zastrow M (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48:537\u2013568","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"478_CR56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1471-4892(01)00091-1","volume":"1","author":"SJ Hill","year":"2001","unstructured":"Hill SJ, Baker JG, Rees S (2001) Reporter-gene systems for the study of G-protein-coupled receptors. Curr Opin Pharmacol 1:526\u2013532","journal-title":"Curr Opin Pharmacol"},{"key":"478_CR57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02791072.1979.10472092","volume":"11","author":"A Hofmann","year":"1979","unstructured":"Hofmann A (1979) How LSD originated. J Psychedelic Drugs 11:53\u201360","journal-title":"J Psychedelic Drugs"},{"key":"478_CR58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"478_CR59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533\u2013554","journal-title":"Pharmacol Biochem Behav"},{"key":"478_CR60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nsmb.2504","volume":"20","author":"J Huang","year":"2013","unstructured":"Huang J, Chen S, Zhang JJ, Huang XY (2013) Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol 20:419\u2013425","journal-title":"Nat Struct Mol Biol"},{"key":"478_CR61","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature12000","volume":"495","author":"R Irannejad","year":"2013","unstructured":"Irannejad R, Tomshine JC, Tomshine JR, Chevalier M, Mahoney JP, Steyaert J, Rasmussen SG, Sunahara RK, El-Samad H, Huang B, von Zastrow M (2013) Conformational biosensors reveal GPCR signalling from endosomes. Nature 495:534\u2013538","journal-title":"Nature"},{"key":"478_CR62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00178722","volume":"354","author":"MP Johnson","year":"1996","unstructured":"Johnson MP, Siegel BW, Carr AA (1996) [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand. Naunyn Schmiedebergs Arch Pharmacol 354:205\u2013209","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"478_CR63","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M113.036558","volume":"13","author":"S Karaki","year":"2014","unstructured":"Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prezeau L, Bockaert J, Marin P, Vandermoere F (2014) Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists. Mol Cell Proteomics 13:1273\u20131285","journal-title":"Mol Cell Proteomics"},{"key":"478_CR64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","volume":"53","author":"V Katritch","year":"2013","unstructured":"Katritch V, Cherezov V, Stevens RC (2013) Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol 53:531\u2013556","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"478_CR65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-6147(00)89032-X","volume":"16","author":"T Kenakin","year":"1995","unstructured":"Kenakin T (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci 16:232\u2013238","journal-title":"Trends Pharmacol Sci"},{"key":"478_CR66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0165-6147(97)90673-8","volume":"18","author":"T Kenakin","year":"1997","unstructured":"Kenakin T (1997) Agonist-specific receptor conformations. Trends Pharmacol Sci 18:416\u2013417","journal-title":"Trends Pharmacol Sci"},{"key":"478_CR67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.42.091401.113012","volume":"42","author":"T Kenakin","year":"2002","unstructured":"Kenakin T (2002) Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42:349\u2013379","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"478_CR68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","volume":"30","author":"H Kiu","year":"2012","unstructured":"Kiu H, Nicholson SE (2012) Biology and significance of the JAK\/STAT signalling pathways. Growth Factors 30:88\u2013106","journal-title":"Growth Factors"},{"key":"478_CR69","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.7569905","volume":"269","author":"HC Kornau","year":"1995","unstructured":"Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269:1737\u20131740","journal-title":"Science"},{"key":"478_CR70","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"TS Krebs","year":"2012","unstructured":"Krebs TS, Johansen PO (2012) Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol 26:994\u20131002","journal-title":"J Psychopharmacol"},{"key":"478_CR71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.102.042184","volume":"304","author":"DM Kurrasch-Orbaugh","year":"2003","unstructured":"Kurrasch-Orbaugh DM, Watts VJ, Barker EL, Nichols DE (2003a) Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J Pharmacol Exp Ther 304:229\u2013237","journal-title":"J Pharmacol Exp Ther"},{"key":"478_CR72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","volume":"86","author":"DM Kurrasch-Orbaugh","year":"2003","unstructured":"Kurrasch-Orbaugh DM, Parrish JC, Watts VJ, Nichols DE (2003b) A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J Neurochem 86:980\u2013991","journal-title":"J Neurochem"},{"key":"478_CR73","doi-asserted-by":"crossref","first-page":"26732","DOI":"10.1074\/jbc.M109.026922","volume":"284","author":"AJ Kuszak","year":"2009","unstructured":"Kuszak AJ, Pitchiaya S, Anand JP, Mosberg HI, Walter NG, Sunahara RK (2009) Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem 284:26732\u201326741","journal-title":"J Biol Chem"},{"key":"478_CR74","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1113\/jphysiol.2014.272997","volume":"592","author":"NA Lambert","year":"2014","unstructured":"Lambert NA, Javitch JA (2014) CrossTalk opposing view: weighing the evidence for class A GPCR dimers, the jury is still out. J Physiol 592:2443\u20132445","journal-title":"J Physiol"},{"key":"478_CR75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1113\/jphysiol.1909.sp001336","volume":"39","author":"JN Langley","year":"1909","unstructured":"Langley JN (1909) On the contraction of muscle, chiefly in relation to the presence of \u2018receptive\u2019 substances. J Physiol 39:235\u2013295","journal-title":"J Physiol"},{"key":"478_CR76","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neulet.2006.01.021","volume":"398","author":"Y Lee","year":"2006","unstructured":"Lee Y, Duman RS, Marek GJ (2006) The mGlu2\/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression. Neurosci Lett 398:328\u2013332","journal-title":"Neurosci Lett"},{"key":"478_CR77","doi-asserted-by":"crossref","unstructured":"Lee MY, Chiang CC, Chiu HY, Chan MH, Chen HH (2014) N-acetylcysteine modulates hallucinogenic 5-HT receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies. Neuropharmacology","DOI":"10.1016\/j.neuropharm.2014.02.006"},{"key":"478_CR78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-6147(93)90048-O","volume":"14","author":"RJ Lefkowitz","year":"1993","unstructured":"Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303\u2013307","journal-title":"Trends Pharmacol Sci"},{"key":"478_CR79","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/PL00005075","volume":"356","author":"JF Lopez-Gimenez","year":"1997","unstructured":"Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (1997) Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedebergs Arch Pharmacol 356:446\u2013454","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"478_CR80","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0028-3908(98)00102-6","volume":"37","author":"JF Lopez-Gimenez","year":"1998","unstructured":"Lopez-Gimenez JF, Vilaro MT, Palacios JM, Mengod G (1998) [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain. Neuropharmacology 37:1147\u20131158","journal-title":"Neuropharmacology"},{"key":"478_CR81","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1046\/j.1460-9568.1999.00827.x","volume":"11","author":"JF Lopez-Gimenez","year":"1999","unstructured":"Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (1999) Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](\u00b1)DOI and [3H]ketanserin. Eur J Neurosci 11:3761\u20133765","journal-title":"Eur J Neurosci"},{"key":"478_CR82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X","volume":"429","author":"JF Lopez-Gimenez","year":"2001","unstructured":"Lopez-Gimenez JF, Vilaro MT, Palacios JM, Mengod G (2001) Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies. J Comp Neurol 429:571\u2013589","journal-title":"J Comp Neurol"},{"key":"478_CR83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12033-008-9031-1","volume":"39","author":"LM Luttrell","year":"2008","unstructured":"Luttrell LM (2008) Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors. Mol Biotechnol 39:239\u2013264","journal-title":"Mol Biotechnol"},{"key":"478_CR84","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1242\/jcs.115.3.455","volume":"115","author":"LM Luttrell","year":"2002","unstructured":"Luttrell LM, Lefkowitz RJ (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115:455\u2013465","journal-title":"J Cell Sci"},{"key":"478_CR85","doi-asserted-by":"crossref","first-page":"E2492","DOI":"10.1073\/pnas.1323287111","volume":"111","author":"NV Malkova","year":"2014","unstructured":"Malkova NV, Gallagher JJ, Yu CZ, Jacobs RE, Patterson PH (2014) Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia. Proc Natl Acad Sci U S A 111:E2492\u20132500","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","volume":"485","author":"A Manglik","year":"2012","unstructured":"Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S (2012) Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485:321\u2013326","journal-title":"Nature"},{"key":"478_CR87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-3565(24)35262-0","volume":"292","author":"GJ Marek","year":"2000","unstructured":"Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76\u201387","journal-title":"J Pharmacol Exp Ther"},{"key":"478_CR88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(01)00199-3","volume":"105","author":"GJ Marek","year":"2001","unstructured":"Marek GJ, Wright RA, Gewirtz JC, Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105:379\u2013392","journal-title":"Neuroscience"},{"key":"478_CR89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00213-002-1141-z","volume":"164","author":"D Marona-Lewicka","year":"2002","unstructured":"Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE (2002) Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats. Psychopharmacology 164:93\u2013107","journal-title":"Psychopharmacology"},{"key":"478_CR90","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","volume":"21","author":"R Martin-Ruiz","year":"2001","unstructured":"Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856\u20139866","journal-title":"J Neurosci"},{"key":"478_CR91","doi-asserted-by":"crossref","unstructured":"Mengod G, Vilaro MT, Cortes R, Lopez-Gimenez JF, Raurich A, Palacios JM (2006) Chemical neuroanatomy of 5-HT receptor subtypes in the mammalian brain. In Roth BL (ed) serotonin T, and therapeutics rFmpth. Humana Press, pp 319\u2013364","DOI":"10.1007\/978-1-59745-080-5_10"},{"issue":"9","key":"478_CR92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","volume":"29","author":"M MILLAN","year":"2008","unstructured":"Millan MJ, Marin P, Bockaert J, la Cour CM (2008) Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 29:454\u2013464","journal-title":"Trends in Pharmacological Sciences"},{"key":"478_CR93","doi-asserted-by":"crossref","unstructured":"Milligan G (2013) The prevalence, maintenance and relevance of GPCR oligomerization. Mol Pharmacol 158\u2013169 (Epub ahead of print)","DOI":"10.1124\/mol.113.084780"},{"key":"478_CR94","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/32937","volume":"392","author":"R Mitchell","year":"1998","unstructured":"Mitchell R, McCulloch D, Lutz E, Johnson M, MacKenzie C, Fennell M, Fink G, Zhou W, Sealfon SC (1998) Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392:411\u2013414","journal-title":"Nature"},{"key":"478_CR95","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","volume":"31","author":"LF Mohammad-Zadeh","year":"2008","unstructured":"Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM (2008) Serotonin: a review. J Vet Pharmacol Ther 31:187\u2013199","journal-title":"J Vet Pharmacol Ther"},{"key":"478_CR96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-3565(25)22012-2","volume":"227","author":"DJ Mokler","year":"1983","unstructured":"Mokler DJ, Commissaris RL, Warner MR, Rech RH (1983) Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists. J Pharmacol Exp Ther 227:557\u2013562","journal-title":"J Pharmacol Exp Ther"},{"key":"478_CR97","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","volume":"67","author":"FA Moreno","year":"2006","unstructured":"Moreno FA, Wiegand CB, Taitano EK, Delgado PL (2006) Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry 67:1735\u20131740","journal-title":"J Clin Psychiatry"},{"key":"478_CR98","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","volume":"493","author":"JL Moreno","year":"2011","unstructured":"Moreno JL, Holloway T, Albizu L, Sealfon SC, Gonzalez-Maeso J (2011) Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett 493:76\u201379","journal-title":"Neurosci Lett"},{"key":"478_CR99","doi-asserted-by":"crossref","first-page":"44301","DOI":"10.1074\/jbc.M112.413161","volume":"287","author":"JL Moreno","year":"2012","unstructured":"Moreno JL, Muguruza C, Umali A, Mortillo S, Holloway T, Pilar-Cuellar F, Mocci G, Seto J, Callado LF, Neve RL, Milligan G, Sealfon SC, Lopez-Gimenez JF, Meana JJ, Benson DL, Gonzalez-Maeso J (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A.mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem 287:44301\u201344319","journal-title":"J Biol Chem"},{"issue":"410","key":"478_CR100","doi-asserted-by":"crossref","first-page":"ra5","DOI":"10.1126\/scisignal.aab0467","volume":"9","author":"Jos\u00e9 L. Moreno","year":"2016","unstructured":"Moreno JL, Miranda-Azpiazu P, Garcia-Bea A, Younkin J, Cui M, Kozlenkov A, Ben-Ezra A, Voloudakis G, Fakira AK, Baki L, Ge Y, Georgakopoulos A, Moron JA, Milligan G, Lopez-Gimenez JF, Robakis NK, Logothetis DE, Meana JJ, Gonzalez-Maeso J (2016) Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia. Sci Signal 9:ra5","journal-title":"Science Signaling"},{"key":"478_CR101","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.euroneuro.2012.10.006","volume":"23","author":"C Muguruza","year":"2013","unstructured":"Muguruza C, Moreno JL, Umali A, Callado LF, Meana JJ, Gonzalez-Maeso J (2013) Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects. Eur Neuropsychopharmacol 23:852\u2013864","journal-title":"Eur Neuropsychopharmacol"},{"key":"478_CR102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181","journal-title":"Pharmacol Ther"},{"key":"478_CR103","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","volume":"108","author":"DE Nichols","year":"2008","unstructured":"Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108:1614\u20131641","journal-title":"Chem Rev"},{"key":"478_CR104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrn3530","volume":"14","author":"DJ Nutt","year":"2013","unstructured":"Nutt DJ, King LA, Nichols DE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci 14:577\u2013585","journal-title":"Nat Rev Neurosci"},{"key":"478_CR105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrm2299","volume":"9","author":"WM Oldham","year":"2008","unstructured":"Oldham WM, Hamm HE (2008) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9:60\u201371","journal-title":"Nat Rev Mol Cell Biol"},{"key":"478_CR106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.placenta.2010.02.019","volume":"31","author":"T Oufkir","year":"2010","unstructured":"Oufkir T, Arseneault M, Sanderson JT, Vaillancourt C (2010) The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1\/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines. Placenta 31:439\u2013447","journal-title":"Placenta"},{"key":"478_CR107","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993\u2013996","journal-title":"Nat Rev Drug Discov"},{"key":"478_CR108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(85)90857-1","volume":"346","author":"A Pazos","year":"1985","unstructured":"Pazos A, Cortes R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231\u2013249","journal-title":"Brain Res"},{"key":"478_CR109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-4522(87)90327-7","volume":"21","author":"A Pazos","year":"1987","unstructured":"Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain\u2013IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123\u2013139","journal-title":"Neuroscience"},{"key":"478_CR110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0026-895X(25)13812-1","volume":"16","author":"SJ Peroutka","year":"1979","unstructured":"Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687\u2013699","journal-title":"Mol Pharmacol"},{"key":"478_CR111","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","volume":"3","author":"KL Pierce","year":"2002","unstructured":"Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639\u2013650","journal-title":"Nat Rev Mol Cell Biol"},{"key":"478_CR112","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0702751","volume":"128","author":"RH Porter","year":"1999","unstructured":"Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13\u201320","journal-title":"Br J Pharmacol"},{"key":"478_CR113","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1073\/pnas.1524187113","volume":"113","author":"KH Preller","year":"2016","unstructured":"Preller KH, Pokorny T, Hock A, Kraehenmann R, Stampfli P, Seifritz E, Scheidegger M, Vollenweider FX (2016) Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing. Proc Natl Acad Sci U S A 113:5119\u20135124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR114","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","volume":"27","author":"KH Preller","year":"2017","unstructured":"Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stampfli P, Liechti ME, Seifritz E, Vollenweider FX (2017) The fabric of meaning and subjective effects in lsd-induced states depend on serotonin 2a receptor activation. Curr Biol 27:451\u2013457","journal-title":"Curr Biol"},{"key":"478_CR115","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","volume":"13","author":"MV Puig","year":"2003","unstructured":"Puig MV, Celada P, Diaz-Mataix L, Artigas F (2003) In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex 13:870\u2013882","journal-title":"Cereb Cortex"},{"key":"478_CR116","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0021-9258(18)57137-4","volume":"176","author":"MM Rapport","year":"1948","unstructured":"Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem 176:1243\u20131251","journal-title":"J Biol Chem"},{"key":"478_CR117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","volume":"92","author":"JR Raymond","year":"2001","unstructured":"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92:179\u2013212","journal-title":"Pharmacol Ther"},{"key":"478_CR118","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/169801a0","volume":"169","author":"G Reid","year":"1952","unstructured":"Reid G, Rand M (1952) Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin). Nature 169:801\u2013802","journal-title":"Nature"},{"key":"478_CR119","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/emboj.2009.177","volume":"28","author":"ML Rives","year":"2009","unstructured":"Rives ML, Vol C, Fukazawa Y, Tinel N, Trinquet E, Ayoub MA, Shigemoto R, Pin JP, Prezeau L (2009) Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J 28:2195\u20132208","journal-title":"EMBO J"},{"key":"478_CR120","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/mol.64.5.1239","volume":"64","author":"DN Robertson","year":"2003","unstructured":"Robertson DN, Johnson MS, Moggach LO, Holland PJ, Lutz EM, Mitchell R (2003) Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor. Mol Pharmacol 64:1239\u20131250","journal-title":"Mol Pharmacol"},{"key":"478_CR121","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature08144","volume":"459","author":"DM Rosenbaum","year":"2009","unstructured":"Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459:356\u2013363","journal-title":"Nature"},{"key":"478_CR122","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jnr.23198","volume":"91","author":"MA Santini","year":"2013","unstructured":"Santini MA, Ratner C, Aznar S, Klein AB, Knudsen GM, Mikkelsen JD (2013) Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia. J Neurosci Res 91:634\u2013641","journal-title":"J Neurosci Res"},{"key":"478_CR123","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","volume":"30","author":"CL Schmid","year":"2010","unstructured":"Schmid CL, Bohn LM (2010) Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a \u00df-arrestin2\/Src\/Akt signaling complex in vivo. J Neurosci official J Soc Neurosci 30:13513\u201313524","journal-title":"J Neurosci official J Soc Neurosci"},{"key":"478_CR124","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1073\/pnas.0708862105","volume":"105","author":"CL Schmid","year":"2008","unstructured":"Schmid CL, Raehal KM, Bohn LM (2008) Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci U S A 105:1079\u20131084","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR125","doi-asserted-by":"crossref","unstructured":"Schmid CL, Streicher JM, Meltzer HY, Bohn LM (2014) Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a betaarrestin2-independent activation of Akt. Neuropsychopharmacology","DOI":"10.1038\/npp.2014.38"},{"issue":"8","key":"478_CR126","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","volume":"78","author":"Yasmin Schmid","year":"2015","unstructured":"Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen R, Muller F, Borgwardt S, Liechti ME (2015) Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry 78:544\u2013553","journal-title":"Biological Psychiatry"},{"key":"478_CR127","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","volume":"20","author":"JL Scruggs","year":"2000","unstructured":"Scruggs JL, Patel S, Bubser M, Deutch AY (2000) DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 20:8846\u20138852","journal-title":"J Neurosci"},{"issue":"12","key":"478_CR128","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","volume":"66","author":"R. A. Sewell","year":"2006","unstructured":"Sewell RA, Halpern JH, Pope HG Jr (2006) Response of cluster headache to psilocybin and LSD. Neurology 66:1920\u20131922","journal-title":"Neurology"},{"key":"478_CR129","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1073\/pnas.0600585103","volume":"103","author":"DJ Sheffler","year":"2006","unstructured":"Sheffler DJ, Kroeze WK, Garcia BG, Deutch AY, Hufeisen SJ, Leahy P, Bruning JC, Roth BL (2006) p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling. Proc Natl Acad Sci U S A 103:4717\u20134722","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nature12120","volume":"497","author":"AK Shukla","year":"2013","unstructured":"Shukla AK, Manglik A, Kruse AC, Xiao K, Reis RI, Tseng WC, Staus DP, Hilger D, Uysal S, Huang LY, Paduch M, Tripathi-Shukla P, Koide A, Koide S, Weis WI, Kossiakoff AA, Kobilka BK, Lefkowitz RJ (2013) Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497:137\u2013141","journal-title":"Nature"},{"key":"478_CR131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00492209","volume":"65","author":"EK Silbergeld","year":"1979","unstructured":"Silbergeld EK, Hruska RE (1979) Lisuride and LSD: dopaminergic and serotonergic interactions in the \u201cserotonin syndrome\u201d. Psychopharmacology 65:233\u2013237","journal-title":"Psychopharmacology"},{"key":"478_CR132","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S1461145708009590","volume":"12","author":"RK Singh","year":"2009","unstructured":"Singh RK, Dai Y, Staudinger JL, Muma NA (2009) Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907. Int J Neuropsychopharmacol 12:651\u2013665","journal-title":"Int J Neuropsychopharmacol"},{"key":"478_CR133","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-6147(98)01175-4","volume":"19","author":"PG Strange","year":"1998","unstructured":"Strange PG (1998) Three-state and two-state models. Trends Pharmacol Sci 19:85\u201386","journal-title":"Trends Pharmacol Sci"},{"issue":"5649","key":"478_CR134","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.1089681","volume":"302","author":"Per Svenningsson","year":"2003","unstructured":"Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (2003) Diverse psychotomimetics act through a common signaling pathway. Science (New York, N.Y.) 302:1412\u20131415","journal-title":"Science"},{"key":"478_CR135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","volume":"44","author":"P Svenningsson","year":"2004","unstructured":"Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269\u2013296","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1 The Neurophar","key":"478_CR136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1990.tb16870.x","volume":"600","author":"ISTVAN T\u00d6RK","year":"1990","unstructured":"Tork I (1990) Anatomy of the serotonergic system. Ann N Y Acad Sci 600:9\u201334; discussion 34\u201335","journal-title":"Annals of the New York Academy of Sciences"},{"key":"478_CR137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","volume":"320","author":"JD Urban","year":"2007","unstructured":"Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1\u201313","journal-title":"J Pharmacol Exp Ther"},{"key":"478_CR138","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"VA Vaidya","year":"1997","unstructured":"Vaidya VA, Marek GJ, Aghajanian GK, Duman RS (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17:2785\u20132795","journal-title":"J Neurosci"},{"key":"478_CR139","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9:3897\u20133902","journal-title":"NeuroReport"},{"key":"478_CR140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0169-328X(94)90133-3","volume":"24","author":"C Waeber","year":"1994","unstructured":"Waeber C, Palacios JM (1994) Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Brain Res Mol Brain Res 24:199\u2013209","journal-title":"Brain Res Mol Brain Res"},{"key":"478_CR141","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1073\/pnas.0611448104","volume":"104","author":"MR Whorton","year":"2007","unstructured":"Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, Sunahara RK (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A 104:7682\u20137687","journal-title":"Proc Natl Acad Sci U S A"},{"key":"478_CR142","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1074\/jbc.M703346200","volume":"283","author":"MR Whorton","year":"2008","unstructured":"Whorton MR, Jastrzebska B, Park PS, Fotiadis D, Engel A, Palczewski K, Sunahara RK (2008) Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem 283:4387\u20134394","journal-title":"J Biol Chem"},{"key":"478_CR143","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330:1066\u20131071","journal-title":"Science"},{"key":"478_CR144","unstructured":"Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485"},{"key":"478_CR145","doi-asserted-by":"crossref","first-page":"47195","DOI":"10.1074\/jbc.M108716200","volume":"276","author":"E Wurmbach","year":"2001","unstructured":"Wurmbach E, Yuen T, Ebersole BJ, Sealfon SC (2001) Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 276:47195\u201347201","journal-title":"J Biol Chem"},{"key":"478_CR146","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(03)00589-X","volume":"122","author":"Z Xia","year":"2003","unstructured":"Xia Z (2003) The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience 122:907\u2013920","journal-title":"Neuroscience"},{"issue":"24","key":"478_CR147","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","volume":"278","author":"Zongqi Xia","year":"2003","unstructured":"Xia Z, Gray JA, Compton-Toth BA, Roth BL (2003) A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J Biol Chem 278:21901\u201321908","journal-title":"Journal of Biological Chemistry"},{"key":"478_CR148","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0076-6879(02)45047-1","volume":"345","author":"T Yuen","year":"2002","unstructured":"Yuen T, Zhang W, Ebersole BJ, Sealfon SC (2002) Monitoring G-protein-coupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol 345:556\u2013569","journal-title":"Methods Enzymol"},{"key":"478_CR149","doi-asserted-by":"crossref","unstructured":"Yuen E, Jiang Q, Chen P, Feng J, Yan Z (2008) Activation of 5-HT2A\/C receptors counteracts 5-HT1A regulation of NMDAR channels in pyramidal neurons of prefrontal cortex. J Biol Chem","DOI":"10.1074\/jbc.M801713200"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Psychedelic Drugs"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2017_478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:09:08Z","timestamp":1750478948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7854_2017_478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783662558782","9783662558805"],"references-count":149,"URL":"https:\/\/doi.org\/10.1007\/7854_2017_478","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}